CID 101944494

Irbesartan metabolite 5

Structural Information

Molecular Formula
C25H28N6O2
SMILES
CCCCC1=NC2(CCC(C2)O)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
InChI
InChI=1S/C25H28N6O2/c1-2-3-8-22-26-25(14-13-19(32)15-25)24(33)31(22)16-17-9-11-18(12-10-17)20-6-4-5-7-21(20)23-27-29-30-28-23/h4-7,9-12,19,32H,2-3,8,13-16H2,1H3,(H,27,28,29,30)
InChIKey
SGLAKMDXJPVHBY-UHFFFAOYSA-N
Compound name
2-butyl-8-hydroxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

444.2274 Da
Monoisotopic Mass

3.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 445.234676 205.4
[M+Na]+ 467.216618 212.4
[M-H]- 443.220124 211.8
[M+NH4]+ 462.261223 212.2
[M+K]+ 483.190558 204.5
[M+H-H2O]+ 427.224660 193.1
[M+HCOO]- 489.225601 217.8
[M+CH3COO]- 503.241251 212.1
[M+Na-2H]- 465.202066 199.3
[M]+ 444.22685142 203.6
[M]- 444.22794858 203.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.